NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval, Atorvastatin patent filing Ruchika Sharma11 Dec 2024 10:00 AM ISTMumbai: Supriya Lifescience Ltd. has acquired approval from Brazil's health authority, ANVISA (Agência Nacional de Vigilância Sanitária), for...
NPPA Hikes Price of Cholesterol-Lowering Drug Atorvastatin Farhat Nasim25 Nov 2024 6:23 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently revised the ceiling price of Atorvastatin 10 mg, a widely used...
Rosuvastatin has Slight Edge Over Atorvastatin in reduction of all cause mortality among patients with dislipedemia, suggests study Dr Riya Dave9 Nov 2024 8:45 AM ISTResearchers have found that while rosuvastatin and atorvastatin are two of the most commonly prescribed drugs in managing cholesterol, rosuvastatin...
Theory to Practice: Implementing Aspirin and Statin Therapy in Primary Care Settings Dr Nishant Tripathi5 Nov 2024 9:00 AM ISTPremature ASCVD in IndiaThe prevalence of atherosclerotic cardiovascular disease (ASCVD) has been increasing in India, surpassing infectious diseases...
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
Impact of Regular Aspirin Use on ASCVD Mortality in Adults with Elevated Lipoprotein(a) Levels Prof. Soumitra Kumar1 Oct 2024 12:52 PM ISTWith a rising incidence of cardiovascular disease (CVD) among younger individuals aged below 55 years(1),particularly in India, where it occurs about...
The Role of Aspirin in Reducing ASCVD Mortality Among Adults with High Lp(a) Concentrations Dr A B Chandorkar8 Aug 2024 11:00 AM ISTAtherosclerotic cardiovascular disease (ASCVD) burden in young individuals is a major health concern, particularly in less developed nations where...
Intas Pharmaceutical Gets CDSCO Panel Nod to Study Atorvastatin plus Fenofibrate FDC Dr. Divya Colin17 July 2024 5:30 PM ISTNew Delhi: The drug major Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Evaluating the Benefits of Aspirin in Lowering ASCVD Mortality for Elevated Lp(a) Individuals Dr. Prem Aggarwal4 July 2024 12:22 PM ISTAtherosclerotic cardiovascular disease (ASCVD) among young adults is a major public health challenge with a global prevalence of 7% to 30%. (1) Due to...
Atorvastatin fails to slow aortic dilatation and valvular calcification progression in bicuspid aortic valve: BICATOR Trial Medha Baranwal7 Jun 2024 9:30 AM ISTSpain: In a significant stride toward managing aortic health, a recent randomized clinical trial, BICATOR (Bicuspid Aortic Valve), has uncovered...
Medical Bulletin 20/October/2023 Isra Zaman20 Oct 2023 3:00 PM ISTHere are the top medical news of the day:A surprising new reason of Long COVIDIn a recent discovery, researchers have unveiled a potential key to...
